US 12,070,383 B2
System for gas treatment of a cell implant
Linda Tempelman, Lincoln, MA (US); Simon Stone, Arlington, MA (US); and Klearchos Papas, Tucson, AZ (US)
Assigned to GINER, INC., Newton, MA (US)
Filed by Giner, Inc., Newton, MA (US)
Filed on Jul. 17, 2023, as Appl. No. 18/222,633.
Application 18/222,633 is a continuation of application No. 16/266,687, filed on Feb. 4, 2019, granted, now 11,701,215.
Application 16/266,687 is a continuation of application No. 14/495,644, filed on Sep. 24, 2014, granted, now 10,231,817, issued on Mar. 19, 2019.
Claims priority of provisional application 61/881,654, filed on Sep. 24, 2013.
Prior Publication US 2024/0189088 A1, Jun. 13, 2024
Int. Cl. A61F 2/02 (2006.01); A61M 5/00 (2006.01); A61M 5/142 (2006.01); A61K 48/00 (2006.01)
CPC A61F 2/022 (2013.01) [A61K 48/0075 (2013.01); A61M 2005/006 (2013.01); A61M 2005/14204 (2013.01); A61M 2202/0208 (2013.01); A61M 2205/7536 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A system for gas treatment of a cell implant, the system comprising:
(a) a gas generating subsystem, the gas generating subsystem comprising
(i) an electrochemical device, the electrochemical device being configured to output a first gas, and
(ii) a semipermeable membrane enclosure, the semipermeable membrane enclosure substantially completely encapsulating the electrochemical device, the semipermeable membrane enclosure being constructed to allow for passage therethrough of reactant needed by the electrochemical device; and
(b) a cell containment subsystem, the cell containment subsystem comprising a first chamber configured to receive cells, the first chamber receiving the first gas outputted by the electrochemical device.